Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126532501 | 12653250 | 1 | I | 20160616 | 20160803 | 20160815 | 20160815 | EXP | GB-MHRA-EYC 00143118 | GB-TEVA-683078ACC | TEVA | 68.00 | YR | M | Y | 82.00000 | KG | 20160816 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126532501 | 12653250 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MILLIGRAM DAILY; | 20 | MG | Y | U | 78773 | 10 | MG | QD | |||
| 126532501 | 12653250 | 2 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 126532501 | 12653250 | 3 | C | ATENOLOL. | ATENOLOL | 1 | 0 | 25 | MG | ||||||||||
| 126532501 | 12653250 | 4 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126532501 | 12653250 | 1 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126532501 | 12653250 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126532501 | 12653250 | Arthralgia | |
| 126532501 | 12653250 | Joint lock | |
| 126532501 | 12653250 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126532501 | 12653250 | 1 | 20160614 | 20160725 | 0 |